Reactions 1704, p160 - 2 Jun 2018 Photoallergy: case report A 60-year-old woman developed photoallergy during treatment with fenofibrate [Catalip 267 micronizado]. The woman, who had hypertriglyceridaemia, started receiving treatment with fenofibrate 267mg daily capsules [route not stated]. She presented with an eczematous eruption on the face, forearms, back of the hands and V-area of the neck with itching and burning, consistent with photosensitivity. The skin eruptions appeared after two weeks of starting fenofibrate. She denied previous use of ketoprofen containing topical product. Photoallergy to fenofibrate was considered. The woman’s fenofibrate was stopped. She was treated with ebastine, prednisolone, betamethasone dipropionate and hydrocortisone, which resulted in complete regression of the rash. After three months, photo-patch and patch tests were carried out. A photo-patch test demonstrated photo-allergy to Author comment: "Fenofibrate is one of the most frequently prescribed drugs for the treatment of hyperlipidaemia. Although cutaneous adverse reactions attributed to the drug occur in ∼2% of patients, photosensitivity is assumed to be rare." Rato M, et al. Fenofibrate photoallergy - relevance of patch and photopatch testing. Contact Dermatitis 78: 413-414, No. 6, Jun 2018. Available from: URL: http:// doi.org/10.1111/cod.12953 - Portugal 803323314 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera